Previous 10 | Next 10 |
home / stock / zldpf / zldpf news
Company announcement – No. 3 / 2023 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, March 9 , 202 3 – Zealand Pharma A/S (“Zealand”) (...
Correction: Company Announcement – No. 2 / 2023 Attachment AGM 2023 Notice - Zealand Pharma A_S (02.03.2023 - FNL for AGM)
Zealand Pharma A/S (ZEAL) Q4 2022 Results Conference Call March 01, 2022 8:00 AM ET Company Participants Anna Krassowska - VP, IR Adam Steensberg - President, CEO Henriette Wennicke - CFO David Kendall - CMO Conference Call Participants Thomas Bowers - ...
Company announcement – No. 1 / 2023 Correction: Zealand Pharma Announces Full Year Results for 2022 Successful organizational transformation and progress across the R&D pipeline Two regulatory submissions anticipated in programs targeting rare diseases ...
Zealand Pharma press release ( OTCPK:ZLDPF ): FY GAAP EPS of - DKK 20.90. Revenue of DKK 104M (-4.1% Y/Y). Cash, cash equivalents, and marketable securities: DKK 1,117.8 million as of December 31, 2022 (December 31, 2021: DKK 1,428 million). Under current p...
Company Announcement – No. 2 / 2023 Attachment Company_Announcement-AGM 2023 Notice - Zealand Pharma
Company announcement – No. 1 / 2023 Zealand Pharma Announces Full Year Results for 2022 Successful organizational transformation and progress across the R&D pipeline Two regulatory submissions anticipated in programs targeting rare diseases Strong mome...
Press release – No. 1 / 2023 Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022 Copenhagen, Denmark February 24, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) a biotechnology company focu...
Zealand Pharma A/S (ZEAL) Q3 2022 Earnings Conference Call November 10, 2022 10:00 AM ET Company Participants Anna Krassowska - Vice President, Investor Relations & Corporate Communications Adam Steensberg - President & Chief Executive Officer Henriette W...
Zealand Pharma A/S (ZEAL) Q2 2022 Earnings Conference Call August 11, 2022, 10:00 AM ET Company Participants Anna Krassowska - VP of IR and Corporate Communications Adam Steensberg - President and CEO Matt Dallas - SVP and CFO David Kendall - Chief Medical Of...
News, Short Squeeze, Breakout and More Instantly...
Zealand Pharma A/S Ord Company Name:
ZLDPF Stock Symbol:
OTCMKTS Market:
Zealand Pharma A/S Ord Website:
Company announcement – No. 35 / 2024 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE U...
Company announcement – No. 34 / 2024 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO T...
Company announcement – No. 33 / 2024 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CAN...